Janux Therapeutics competitorsClear all

Janux Therapeutics's top competitors include Numab, Cybrexa Therapeutics, OncoTherapy Science and CARsgen Therapeutics.
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background
Janux Therapeutics
Janux Therapeutics
Janux Therapeutics is a biopharmaceutical company developing therapeutics to treat patients with cancer.
Numab
Numab
Numab Therapeutics is an oncology-focused biopharmaceutical company.
Cybrexa Therapeutics
Cybrexa Therapeutics
Cybrexa Therapeutics is a biotechnology company developing cancer therapeutics.
OncoTherapy Science
OncoTherapy Science
OncoTherapy Science is a company engaged in research and development of cancer therapeutics.
CARsgen Therapeutics
CARsgen Therapeutics
CARsgen Therapeutics is a clinical-stage immune-oncology company that develops a new chimeric T-cell antigen receptor for liver, lung, stomach and brain cancers treatment.
Founding Date
Founding Date
2017
Founding Date
2011
Founding Date
2016
Founding Date
2001
Founding Date
2014
Type
Type
Public
Type
Private
Type
Private
Type
Public
Type
Private
Tags
Locations
Locations
San Diego, US HQ
Locations
Wädenswil, CH HQ
Locations
New Haven, US HQ
Locations
Kawasaki, JP HQ
Locations
Shanghai, CN HQ
Beijing, CN
Shanghai, CN
Shanghai, CN
Bellaire, US
Employees
Employees
20
Employees
585% increase
Employees
1910% decrease
Employees
66
Employees
1106% increase
Valuation ($)
Valuation ($)
430.7 m
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
97.8 m
Valuation ($)
N/A
Twitter followers
Twitter followers
N/A
Twitter followers
124
Twitter followers
160
Twitter followers
N/A
Twitter followers
100
Number of tweets (last 30 days)
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
15
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
1
Alexa Website Rank
Alexa Website Rank
816802
Alexa Website Rank
909068
Alexa Website Rank
494179
Alexa Website Rank
N/A
Alexa Website Rank
527228
Employee Rating
Employee Rating
N/A
Employee Rating
N/A
Employee Rating
N/A
Employee Rating
N/A
Employee Rating
N/A

Funding

Latest funding round
Latest funding round
N/A
Latest funding round
$ 110m (about 1 year ago)
Latest funding round
$ 25m (about 1 year ago)
Latest funding round
N/A
Latest funding round
$ 186m (over 1 year ago)
Total funding raised
Total funding raised
N/A
Total funding raised
$ 132.3m
Total funding raised
$ 44.4m
Total funding raised
N/A
Total funding raised
$ 276m
For sources of this data, please see the company profile

View company profiles

Numab
HQ
Wädenswil, CH
Employees
58↑ 5% increase

Numab Therapeutics is an oncology-focused biopharmaceutical company.

View company
Cybrexa Therapeutics
HQ
New Haven, US
Employees
19↓ 10% decrease

Cybrexa Therapeutics is a biotechnology company developing cancer therapeutics.

View company
OncoTherapy Science
HQ
Kawasaki, JP
Employees
66

OncoTherapy Science is a company engaged in research and development of cancer therapeutics.

View company
CARsgen Therapeutics
HQ
Shanghai, CN
Employees
110↑ 6% increase

CARsgen Therapeutics is a clinical-stage immune-oncology company that develops a new chimeric T-cell antigen receptor for liver, lung, stomach and brain cancers treatment.

View company